RELAPSING FORMS OF MULTIPLE SCLEROSIS
Clinical trials for RELAPSING FORMS OF MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING FORMS OF MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING FORMS OF MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-world study shows ofatumumab cuts MS relapses
Disease control CompletedThis study looked at how well the drug ofatumumab (Kesimpta®) works in real-world Spanish clinics for people with relapsing multiple sclerosis. Researchers tracked 310 patients to see if the drug reduced the number of relapses (flare-ups of symptoms). The goal was to understand t…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New MS drug combo shows promise in early trial
Disease control CompletedThis study tested a new drug called BIIB091, alone or combined with an existing MS drug (diroximel fumarate), in 127 people with relapsing forms of multiple sclerosis. The goal was to check safety and see if the drug reduces brain inflammation. Participants took pills twice daily…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New MS drug shows promise in Asian-Pacific safety trial
Disease control CompletedThis study tested the safety and tolerability of a drug called diroximel fumarate in 136 adults from the Asia-Pacific region with relapsing forms of multiple sclerosis (MS). Participants took the drug for up to 48 weeks, and researchers monitored side effects, lab results, and ho…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 12, 2026 13:41 UTC